Showing 1 - 20 results of 49 for search 'E. P. Panchenko', query time: 0.02s Refine Results
  1. 1
    Is there still room for warfarin after the appearance of direct oral anticoagulants?

    Is there still room for warfarin after the appearance of direct oral anticoagulants? by E. P. Panchenko

    Published 2023-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    PATIENT WITH CAD AND MULTIFOCAL ARTERIAL SCLEROTIC DISEASE (CLINICAL DISCUSSION)

    PATIENT WITH CAD AND MULTIFOCAL ARTERIAL SCLEROTIC DISEASE (CLINICAL DISCUSSION) by E. P. Panchenko

    Published 2020-01-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    WHAT COULD HAVE BEEN DONE DIFFERENTLY? A PATIENT WITH ACUTE CORONARY SYNDROME

    WHAT COULD HAVE BEEN DONE DIFFERENTLY? A PATIENT WITH ACUTE CORONARY SYNDROME by E. P. Panchenko

    Published 2016-07-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Cardiovascular risk factors and their control in early XXI century (REACH registry data)

    Cardiovascular risk factors and their control in early XXI century (REACH registry data) by E. P. Panchenko

    Published 2006-12-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Antithrombotic therapy in patients with atrial fibrillation and percutaneous coronary intervention: what has changed in the guidelines in 2020?

    Antithrombotic therapy in patients with atrial fibrillation and percutaneous coronary intervention: what has changed in the guidelines in 2020? by E. P. Panchenko

    Published 2020-12-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    HAVE WE SHIFTED OUR PARADIGM OF CLOPIDOGREL AS A MANDATORY DRUG IN TREATMENT OF CARDIOLOGICAL PATIENTS AFTER THE INTRODUCTION OF MORE POWERFUL ANTIAGREGANTS?

    HAVE WE SHIFTED OUR PARADIGM OF CLOPIDOGREL AS A MANDATORY DRUG IN TREATMENT OF CARDIOLOGICAL PATIENTS AFTER THE INTRODUCTION OF MORE POWERFUL ANTIAGREGANTS? by E. P. PANCHENKO

    Published 2017-12-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    CHOICE OF ANTIPLATELET THERAPY IN VARIOUS PATIENTS WITH ACUTE CORONARY SYNDROMES

    CHOICE OF ANTIPLATELET THERAPY IN VARIOUS PATIENTS WITH ACUTE CORONARY SYNDROMES by E. P. Panchenko

    Published 2015-12-01
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    NEW ORAL ANTICOAGULANTS IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION AND CHRONIC KIDNEY DISEASE

    NEW ORAL ANTICOAGULANTS IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION AND CHRONIC KIDNEY DISEASE by E. P. Panchenko

    Published 2015-12-01
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    The place of dabigatran in the treatment of patients with atrial fibrillation in the light of modern recommendations

    The place of dabigatran in the treatment of patients with atrial fibrillation in the light of modern recommendations by E. S. Kropacheva, E. P. Panchenko

    Published 2023-08-01
    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    DABIGATRAN ETEXILATE FOR THE TREATMENT OF VENOUS THROMBOEMBOLIC COMPLICATIONS

    DABIGATRAN ETEXILATE FOR THE TREATMENT OF VENOUS THROMBOEMBOLIC COMPLICATIONS by N. M. Vorobieva, E. P. Panchenko

    Published 2015-12-01
    Get full text
    Article
    Save to List
    Saved in:
  11. 11
    ANTICOAGULANTS IN THERAPY OF PATIENTS WITH ACUTE CORONARY SYNDROME WITHOUT ST SEGMENT ELEVATION: WHICH DRUG TO BE CHOSEN?

    ANTICOAGULANTS IN THERAPY OF PATIENTS WITH ACUTE CORONARY SYNDROME WITHOUT ST SEGMENT ELEVATION: WHICH DRUG TO BE CHOSEN? by A. L. Komarov, E. P. Panchenko

    Published 2016-01-01
    Get full text
    Article
    Save to List
    Saved in:
  12. 12
    THROMBOSES IN ONCOLOGY. PART 1

    THROMBOSES IN ONCOLOGY. PART 1 by Y. A. Fedotkina, E. P. Panchenko

    Published 2017-05-01
    Get full text
    Article
    Save to List
    Saved in:
  13. 13
    THROMBOSIS IN CANCER. PART 2

    THROMBOSIS IN CANCER. PART 2 by Yu. A. FEDOTKINA, E. P. PANCHENKO

    Published 2017-12-01
    Get full text
    Article
    Save to List
    Saved in:
  14. 14
    PRASUGREL: FREQUENTLY ASKED QUESTIONS FROM PRACTITIONERS

    PRASUGREL: FREQUENTLY ASKED QUESTIONS FROM PRACTITIONERS by O. O. Shakhmatova, E. P. Panchenko

    Published 2019-06-01
    Get full text
    Article
    Save to List
    Saved in:
  15. 15
    ANTICOAGULANT THERAPY OF VENOUS THROMBOEMBOLIC COMPLICATIONS: PROBLEMS AND PERSPECTIVES

    ANTICOAGULANT THERAPY OF VENOUS THROMBOEMBOLIC COMPLICATIONS: PROBLEMS AND PERSPECTIVES by N. M. Vorobieva, E. P. Panchenko

    Published 2015-03-01
    Get full text
    Article
    Save to List
    Saved in:
  16. 16
    PLATELET FUNCTION TEST FOR THE ASSESSMENT OF THROMBOSIS AND BLEEDING RISK IN CHD PATIENTS TAKING ANTIPLATELET MEDICATIONS

    PLATELET FUNCTION TEST FOR THE ASSESSMENT OF THROMBOSIS AND BLEEDING RISK IN CHD PATIENTS TAKING ANTIPLATELET MEDICATIONS by A. L. Komarov, E. P. Panchenko

    Published 2015-03-01
    Get full text
    Article
    Save to List
    Saved in:
  17. 17
    Past COVID-19 infection and feasibility of transcatheter aortic valve replacement in a patient with severe aortic stenosis (a clinical case study)

    Past COVID-19 infection and feasibility of transcatheter aortic valve replacement in a patient with severe aortic stenosis (a clinical case study) by O. A. Zemlyanskaya, E. V. Kurilina, E. P. Panchenko

    Published 2022-01-01
    Get full text
    Article
    Save to List
    Saved in:
  18. 18
    THE EFFICACY OF LONG-TERM WARFARIN THERAPY: THE IMPACT ON THE INCIDENCE OF ISCHEMIC CEREBROVASCULAR DISORDERS AND CLINICAL PREDICTORS OF DEVELOPING SUCH DISORDERS. (Results of a prospective 10-year follow-up study)

    THE EFFICACY OF LONG-TERM WARFARIN THERAPY: THE IMPACT ON THE INCIDENCE OF ISCHEMIC CEREBROVASCULAR DISORDERS AND CLINICAL PREDICTORS OF DEVELOPING SUCH DISORDERS. (Results of a pr... by E. S. KROPACHEVA, O. A. ZEMLYANSKAYA, A. B. DOBROVOLSKY, E. P. PANCHENKO

    Published 2017-12-01
    Get full text
    Article
    Save to List
    Saved in:
  19. 19
    SAFETY OF LONG-TERM THERAPY WITH WARFARIN: HEMORRHAGE FREQUENCY AND CLINICAL PREDICTORS (results of a prospective 15-year follow-up)

    SAFETY OF LONG-TERM THERAPY WITH WARFARIN: HEMORRHAGE FREQUENCY AND CLINICAL PREDICTORS (results of a prospective 15-year follow-up) by E. S. Kropacheva, O. A. Zemlyanskaya, E. P. Panchenko, A. B. Dobrovolsky, E. N. Krivosheeva

    Published 2017-05-01
    Get full text
    Article
    Save to List
    Saved in:
  20. 20
    EFFECT OF LONG-TERM ENOXAPARIN THERAPY ON RISK OF RECURRENT VENOUS THROMBOEMBOLIC COMPLICATIONS AND RECANALIZATION OFTHROMBOSED VEINS

    EFFECT OF LONG-TERM ENOXAPARIN THERAPY ON RISK OF RECURRENT VENOUS THROMBOEMBOLIC COMPLICATIONS AND RECANALIZATION OFTHROMBOSED VEINS by N. M. Vorobyova, O. V. Ermolina, T. V. Balakhonova, A. I. Kiriyenko, E. P. Panchenko

    Published 2015-12-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: